NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 317 filers reported holding NATERA INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $51,341,805 | -11.3% | 474,114 | -25.1% | 9.00% | -16.3% |
Q1 2024 | $57,868,022 | +33.7% | 632,714 | -8.4% | 10.75% | +22.3% |
Q4 2023 | $43,275,596 | +64.2% | 690,862 | +16.0% | 8.79% | +51.4% |
Q3 2023 | $26,359,460 | -9.1% | 595,694 | 0.0% | 5.81% | +7.2% |
Q2 2023 | $28,986,470 | -33.5% | 595,694 | -24.1% | 5.42% | -36.1% |
Q1 2023 | $43,577,315 | +33.1% | 784,894 | -3.7% | 8.48% | +12.3% |
Q4 2022 | $32,738,309 | +25.4% | 814,994 | +36.7% | 7.55% | +26.0% |
Q3 2022 | $26,116,000 | +29.1% | 595,994 | +4.4% | 5.99% | +27.0% |
Q2 2022 | $20,236,000 | +11.2% | 570,994 | +27.6% | 4.72% | +5.2% |
Q1 2022 | $18,204,000 | -7.9% | 447,494 | +111.4% | 4.48% | -6.9% |
Q4 2021 | $19,770,000 | +7.9% | 211,694 | +28.7% | 4.82% | -17.1% |
Q3 2021 | $18,331,000 | -1.1% | 164,494 | +0.8% | 5.81% | -8.5% |
Q2 2021 | $18,527,000 | +8.4% | 163,194 | -3.1% | 6.36% | -5.3% |
Q1 2021 | $17,099,000 | +118.6% | 168,394 | +114.2% | 6.71% | +34.2% |
Q4 2020 | $7,822,000 | – | 78,600 | – | 5.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |